2004 suplement 2

Back

Volume 13, suplement 2

Interdisciplinary problems of spasticity

Functional gains after injections of botulinum toxin type A in cerebral palsy patients

Jarosław Sławek1, LILIANA KLIMONT2
1. Oddziału Neurochirurgii Czynnościowej i Chorób Układu Pozapiramidowego Kliniki Neurochirurgii Akademii Medycznej w Gdańsku
2. Ośrodka Wczesnej Interwencji w Gdańsku
Postępy Psychiatrii i Neurologii, 2004, suplement 2 (18), 35-39
Keywords: spasticity, botulinum toin

Abstract

Aim. To present basic data on botulinum toxin type A (BTX-A) in the treatment of cerebral palsy.

Review. BTX-A is nowadays a widely used treatment for spasticity due to cerebral palsy (CP). It is a registered therapy in the majority of European countries and Australia. Before the year 2001 156 studies were published on its usefulness and safety in CP. Nevertheless, there are only few studies regarding the short and long-term functional gains following BTX-A therapy. Recently published data suggest that BTX-A may trigger and produce a better functional outcome in CP patients, despite its transitory effect on muscle lone or passive range of motions. BTX-A seems to be especially useful in younger children (2-6 years old) with mild/moderate focal spasticity, without fixed contractures.

Address for correspondence:
Dr Jarosław Sławek, Oddział Neurochirurgii Czynnościowej i Chorób Układu Pozapiramidowego
Kliniki Neurochirurgii Akademii Medycznej, ul. Dębinki 7, 80-211 Gdańsk, tel./fax: (58) 3455888, e-mail: jaroslawek@amg.gda.pl